IMI 2021 reports and digest - Reflections on the implications for clinical practice

Date

2021

Authors

Wolffsohn, James S
Jong, Monica
Smith III, Earl L
Resnikoff, Serge R.
Jonas, Jost B.
Logan, Nicola S.
Morgan, Ian
Sankaridurg, Padmaja
Ohno-Matsui, K

Journal Title

Journal ISSN

Volume Title

Publisher

Investigative Opthalmology and Visual Science

Abstract

The International Myopia Institute's (IMI) mission is to advance research, education, and management of myopia to decrease future vision impairment and blindness associated with increasing myopia. Its approach is to bring together scientists, clinicians, policymakers, government members, and educators into the field of myopia to stimulate collaboration and sharing of knowledge. The latest reports are on pathologic myopia, the impact of myopia, risk factors for myopia, accommodation and binocular vision in myopia development and progression, and the prevention of myopia and its progression. Together with the digest updating the 2019 International Myopia Institute white papers using the research published in the last 18 months, these evidence-based consensus white papers help to clarify the imperative for myopia control and the role of environmental modification initiatives, informing an evidence-based clinical approach. This guidance includes who to treat and when to start or stop treatment, and the advantages and limitations of different management approaches.

Description

Keywords

myopia, refractive error, pathologic myopia, myopia control, accommodation

Citation

Source

Investigative Ophthalmology and Visual Science

Type

Journal article

Book Title

Entity type

Access Statement

Open Access

License Rights

Creative Commons Attribution-NonCommercial-NoDerivs License

DOI

10.1167/iovs.62.5.1

Restricted until